Prognostic Stratification of Patients with Burkitt Lymphoma Using Serum β2-microglobulin Levels - Kim, Hyung-Don; Cho, Hyungwoo; Kim, Shin; Lee, Kyoungmin; Kang, Eun Hee; Park, Jung Sun; Park, Chan-Sik; Huh, Jooryung; Ryu, Jin Sook; Lee, Sang-Wook; Yoon, Dok-Hyun; Kim, Seok Jin; et al. (Cancer research and treatment, 2021)
Keywords: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; beta 2-Microglobulin - blood; Biomarkers, Tumor - blood; Burkitt Lymphoma - blood; Burkitt Lymphoma - drug therapy; Burkitt Lymphoma - mortality; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Original; Predictive Value of Tests; Prognosis; Progression-Free Survival; Prospective Studies; Retrospective Studies; Risk Assessment - methods; Risk Factors; Survival Rate; Young Adult; 의학일반; Prognosis; β2-microglobulin; Burkitt lymphoma; Risk stratification